Alnylam Pharmaceuticals, Inc. carries a market capitalization of 49.93B, placing it among publicly traded companies globally.
| Market Cap | 49.93B |
| Enterprise Value | N/A |
Alnylam Pharmaceuticals, Inc.'s stock has gained approximately 17.51029% over the past 52 weeks. The 50-day moving average sits at 170.73, while the 200-day moving average is 180.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | 17.51029% |
| 50-Day Moving Average | 170.73 |
| 200-Day Moving Average | 180.79 |
| Average Volume (20 Days) | N/A |